How can we win the fight against TB?
Tuberculosis (TB) has managed to remain a major global health problem, despite 100 years of research and more than 50 years of treatment being available. It still claims up to 1.5 million...
Mohlopheni Jackson Marakalala is a Senior Lecturer and a Group Leader in the Division of Immunology, University of Cape Town. He is also a Visiting Scientist at Harvard School of Public Health, where he recently completed a 4 year postdoctoral fellowship in infectious diseases. He is one of the current Next Einstein Fellows, and was recently honored by World Economic Forum as a Young Scientist. Mohlopheni hopes to discover new therapeutic and diagnostic tools to combat infectious diseases mostly prevalent in Sub-Saharan Africa. His laboratory research focuses on the development of better therapies against Tuberculosis. He hopes to contribute towards public dialogues that will help inform better health policies. He also envisions building research capacity in Africa by training PhD students from disadvantaged communities.
最热内容